E134: Brepocitinib in Dermatomyositis (VALOR)
Great trial this week looking at brepocitinib in dermatomyositis. Looks like a winner, expect it will be approved. Where it fits in our approach to IIM is an open question, but nice to have another option. Study: https://www.nejm.org/doi/10.1056/NEJMoa2503531 JC Companion: https://autoimmunedevreport.substack.com/
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Evidence Based Rheumatology Podcast
E135: IL17 and a GLP1?
E133: Obinutuzumab for SLE (ALLEGORY)
E132: Romosozumab vs teriparatide for osteoproosis (STRUCTURE)
E131: A Sham-Controlled Sham of a Trial: RESET-RA
Get summaries like this every morning.
Free AI-powered recaps of The Evidence Based Rheumatology Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.